Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
BeOne’s Venclexta Challenger Beqalzi Wins FDA Approval as First BCL-2 for Mantle Cell Lymphoma
BeOne Medicines has entered the BCL-2 space, securing FDA green light for Beqalzi, carving out…
CEOs of major pharmaceutical companies were conspicuously absent during President Trump’s arrival in China
As President Donald Trump arrives in Beijing, one key industry is missing from his business…
In April 2025, Merck KGaA acquired SpringWorks Therapeutics, a Connecticut-based company specializing in rare diseases,…
Takeda Pharmaceutical plans to cut 4,500 jobs in the latest restructuring drive as it slims down for a “new era”
With a new CEO set to take over next month and three major launches planned…
As GLP-1 competition intensifies, Novo and Lilly tout their respective early response and weight loss maintenance data
Eli Lilly and Novo Nordisk are building a case for both old and new incretin…
BioMarin consolidates staff at Amicus headquarters after closing $4.8 billion deal with rare disease peer
BioMarin Pharmaceuticals is consolidating employees tied to the acquired company’s headquarters in Princeton, New Jersey,…
Dr. Marty McCulley will step down as FDA commissioner on Tuesday, ending a short but…
Eli Lilly suspends India obesity awareness campaign following regulatory notice: report
According to Reuters, Eli Lilly has suspended its obesity awareness campaign in India following a…
As public criticism of vaccines subsides, RFK Jr. continues to investigate safety behind the scenes: NYT
The Secretary of Health and Human Services is said to be campaigning behind the scenes…
Alkermes’ Lumryz hits Phase 3 mark in another sleep disorder, momentum accelerates with $2.4 billion Avadel acquisition
Marking a quick clinical win with its $2.37 billion acquisition of Avadel, Alkermes reported on…